The Health, Education, Labor and Pensions Committee today held the first in a series of hearings on how to reduce health care costs, which will examine administrative costs and waste, how to improve transparency, private sector solutions and other issues. Witnesses at today鈥檚 included representatives from the Department of Health Policy at Vanderbilt University School of Medicine, Harvard Global Health Institute, Health Care Cost Institute and Georgetown University Law Center. In a statement submitted to the committee, AHA encouraged Congress to 鈥減ursue actions that will help reduce the cost of coverage without putting access to care at risk,鈥 including addressing the high costs of prescription drugs, regulatory and administrative burden, and chronic disease, and 鈥減romoting enrollment in comprehensive health coverage to share costs across the broadest population possible.鈥 While the share of national health expenditures for hospital care has declined and hospital price growth remains under 2%, spending for retail and inpatient prescription drugs have surged and hospitals 鈥渃ontinue to provide a significant amount of uncompensated care,鈥 increasingly because 鈥渋ndividuals who have insurance cannot meet their high deductibles and other cost-sharing requirements,鈥 the statement notes.

Related News Articles

Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the鈥
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug鈥
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy鈥
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation鈥
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at鈥
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥